MedTrace Logo

Phosphate Binding of Chitosan Chewing Gum in Patients With Chronic Kidney Disease (CKD)

NCT01341691 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2011-04-26

No results posted yet for this study

Summary

To determine the amount of phosphate recovered into 2 strengths of K2CG chewing gum in a modified formulation (with or without an extender) added to the gum core, in comparison to matching placebo gums.

Conditions

Interventions

OTHER

chewing gum

single piece of chewing gum containing specified amount of chitosan with or without extender chewed twice daily for 14 days

Sponsors & Collaborators

  • CM&D Pharma, LTD

    collaborator UNKNOWN

  • Denver Nephrologists, P.C.

    lead OTHER

Principal Investigators

  • Geoffrey A Block, MD · Denver Nephrologists, PC

Study Design

Allocation
NON_RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2011-04-30
Completion
2011-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01341691 on ClinicalTrials.gov